Please use symbol entry at top right of page to search

Botulinum Toxin Market size worth $ 14.76 Billion, Globally, by 2030 at 8.2% CAGR: Verified Market Research®

The growing need for cosmetic procedures, growing research and development programs to increase the use of botulinum toxin, and the patient's growing preference for non-invasive treatments are some of the factors to lead the growth of the market.

JERSEY CITY, N.J., May 12, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Botulinum Toxin Market" By Type (Botulinum Toxin Type A, Botulinum Toxin Type B), By Application (Aesthetic, Therapeutics), By End-User (Beauty Centers And Spas, Hospitals And Clinics), and By Geography. According to Verified Market Research, the Global Botulinum Toxin Market size was valued at USD 7.32 Billion in 2021 and is projected to reach USD 14.76 Billion by 2030, growing at a CAGR of 8.2% from 2022 to 2030.

Verified_Market_Research_Logo

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=10557

Browse in-depth TOC on "Botulinum Toxin Market"

202 - Pages

126 – Tables

37 – Figures

Global Botulinum Toxin Market Overview

An increase in life expectancy has also increased the average age of people worldwide. Due to the growing age of the people, there is a surge in the importance of beauty and good looks, which has positively affected the need for Botox treatment. Botox can treat several medical conditions like excessive sweating, migraine, neuralgia, overactive bladder, spasticity, and rest others. Due to its propensity of blocking neurotransmitters that send pain signals to the brain, it is used widely to treat migraine and also cosmetic non-invasive surgical procedures. An increase in life expectancy, surge in demand for cosmetic non-invasive surgical procedures, rapid approval and launch of new products, affordability increment, amendments in reimbursement policies for covering Botox treatment, and others, have pushed the growth of the market. One of the major players in this industry, AbbVie, has received the approval for Botox treatment of detrusor over activity associated with the neurological condition for pediatric patients of 5-year age and older in 2021.

Additionally, inclination toward looking good and aesthetic beauty followed by a rapid increase in the use of Botox in different chronic and critical diseases drives up the market of botulinum toxin globally. A growing level of care has improved professional services, and the availability of minimally invasive surgery by skilled surgeons has contributed to the growth of the procedure. As per the American Society of Plastic Surgeons, 13.3 million minimally invasive cosmetic procedure was done in 2020, where Botox type A tops the list with nearly 4.4 million procedures. Adding to it, in the latter half of 2020, both men and women opted for a huge number of cosmetic procedures. However, one of the major restraints of the market is its availability to different parties, which generates chances of counterfeit medication. High price, adverse events such as injection site bruising or swelling, headache, or flu-like effects, and the inability of using in pregnant women among others, are considered to be major restraints of the market.

Key Developments

  • April 2022 – PatientFi, an emerging company in the sector of patient payments making elective procedure cost more affordable, has expanded its co-marketing agreement with Allergan Aesthetics, to provide the option for financing to the patients interested in treatments like Botox among others.
  • August 2021 – Merz Therapeutics received approval from the Russian Federal Service for Surveillance in Healthcare for the use of Xeomin, a neurotoxin named incobutlinumtoxinA for the treatment of chronic sialorrhea due to neurodevelopmental disorders in children between 2-17 years of age.
  • June 2021 – Hugel America Inc. got approval on Biologics License Application by the USFDA for its Letibotulinumtoxin A.

Key Players

The major players in the market are Lanzhou Institute of Biological Products Co. Ltd., Merz Pharma GmbH & Co. KgaA, US Worldmed LLC, Allergan, Inc., Revance Therapeutics, Inc., Ipsen Group, Medytox, Inc., Nestlé Skin Health, Hugel Inc., AbbVie Inc. (Allergan), Galderma, and Evolus, Inc. and Metabiologics, Inc.

Verified Market Research has segmented the Global Botulinum Toxin Market On the basis of Type, Application, End-User, and Geography.

  • Botulinum Toxin Market, By Type
    • Botulinum Toxin Type A
    • Botulinum Toxin Type B
  • Botulinum Toxin Market, By Application
    • Aesthetic
    • Therapeutics
  • Botulinum Toxin Market, By End-User
    • Beauty Centers and spas
    • Hospitals and clinics
    • Others
  • Botulinum Toxin Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Vegan Beauty Products Market By Product (Hair Care, Skin Care, Make-up, Fragrance), By Application (Women, Men, and Kids), By Geography, Forecast, 2021-2028

Cosmetic Antioxidants Market By Source (Natural, Chemically Derived), By Type (Carotenoids, Enzymes, Polyphenols), By Application (Skin Care, Hair Care, Makeup), By Function (Anti-aging, Anti-inflammatory, UV Protection), By Geography, Forecast, 2021-2028

Cosmetics OEM/ODM Market By Type (OEM and ODM), By Application (Skincare, Makeup, Haircare, and Others), By Geography, Forecast, 2021-2028

Botulinum Neurotoxins Market By Type (Botulinum Neurotoxins A (BoNT/A), Botulinum Neurotoxins B (BoNT/B)), By Application (Medical Uses, Cosmetics), By Geography, Forecast, 2021-2028

Top 10 Cosmetics Companies polishing the appearance to give a royal look

Visualize Botulinum Toxin Market using Verified Market Intelligence:-

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us
Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: 1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Cision View original content:https://www.prnewswire.com/news-releases/botulinum-toxin-market-size-worth--14-76-billion-globally-by-2030-at-8-2-cagr-verified-market-research-301546193.html

SOURCE Verified Market Research

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.